Secai Secures $6.2M Series A Funding for Voxira AI Healthcare Automation Expansion
Secai, a Montreal-based health AI company, has raised $6.2M in Series A funding to enhance healthcare automation with its Voxira and NoteGen platforms. The financing will facilitate commercial growth, improve engineering capabilities, and promote adoption in Canada and the U.S. Secai's voice AI technology has gained traction, becoming the only one certified by the Quebec Ministry of Health. The funding aims to expand nationwide, deepen EMR integrations, and advance clinical R&D.
Theia Market Signal Identification - AI Assisted
Montreal-based Secai has raised $6.2M in Series A funding to scale its Voxira and NoteGen healthcare automation solutions. The funding will support expansion across Canada and the U.S., enhance engineering and product capabilities, and deepen integrations with major EMR platforms.
Secai's voice AI technology is the only one certified by the Quebec Ministry of Health as of August 2025. The company aims to improve operational efficiency and patient outcomes in clinics, driven by a strong clinical foundation and early adoption by health systems. The investment will also advance R&D in clinical reasoning and agentic workflows.
Comments